# RPRX (Royalty Pharma plc) - SEC EDGAR Financial Statements

> Royalty Pharma plc reported $2.62B in revenue and net income of $672.5M for the trailing twelve months ended September 30, 2026 (up 13.3% year over year), with a 57.1% operating margin.

- Canonical: https://convexityos.com/fundamentals/RPRX
- Markdown: https://convexityos.com/fundamentals/RPRX.md
- SEC CIK: 0001802768
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:04 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001802768&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $2.62B | +13.3% YoY |
| Operating Income | TTM | $1.50B | 57.1% margin |
| Net Income | TTM | $672.5M | 25.7% net margin |
| Diluted EPS | TTM | $1.21 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $544.9M | Total debt: $8.59B |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $2.38B | $2.26B | $2.35B | $2.24B | $2.29B | $2.12B | $1.81B | $1.79B |
| Research & Development | $452.0M | $2.00M | $52.00M | $177.1M | $200.1M | $26.29M | $83.04M | $392.6M |
| **Operating Income** | $1.56B | $1.29B | $1.49B | $307.1M | $1.43B | $1.60B | $2.62B | $1.36B |
| **EBITDA** | $1.56B | $1.29B | $1.49B | -- | -- | -- | -- | -- |
| Interest Income | $33.59M | $47.34M | $72.29M | $78.33M | -- | -- | -- | -- |
| Interest Expense | $307.7M | $225.5M | $187.2M | $188.0M | $166.1M | $157.1M | $268.6M | $280.0M |
| Income Before Tax | $1.32B | $1.33B | $1.70B | $230.1M | $1.24B | $1.70B | $2.46B | $1.52B |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | $770.9M | $859.0M | $1.13B | $42.83M | $619.7M | $975.0M | $2.35B | $1.38B |
| Basic EPS | $1.79 | $1.92 | $2.54 | $0.10 | $1.49 | $1.32 | -- | -- |
| **Diluted EPS** | $1.78 | $1.91 | $2.53 | $0.10 | $1.49 | $1.32 | -- | -- |
| Basic Shares Outstanding | 429.8M | 448.2M | 447.6M | 438.0M | 414.8M | 375.4M | -- | -- |
| Diluted Shares Outstanding | 564.5M | 594.1M | 602.9M | 438.0M | 414.8M | 375.5M | -- | -- |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $690.1M | $674.1M | $630.6M | $622.0M | $609.3M | $578.7M | $568.2M | $593.6M |
| Research & Development | $63.16M | $97.85M | $39.79M | $50.50M | $50.50M | $300.5M | $50.50M | $500K |
| **Operating Income** | $410.8M | $133.1M | $563.0M | $388.4M | $427.2M | $209.8M | $534.2M | $361.5M |
| **EBITDA** | $412.1M | $134.4M | $564.2M | $389.6M | $428.4M | $211.2M | $534.2M | -- |
| Interest Income | $5.34M | $5.13M | $6.23M | $7.07M | $6.90M | $8.33M | $11.29M | $9.04M |
| Interest Expense | $90.49M | $93.62M | $93.72M | $94.17M | $79.56M | $68.67M | $65.26M | $65.76M |
| Income Before Tax | $266.6M | $81.49M | $468.3M | $356.9M | $440.2M | $92.64M | $434.4M | $334.4M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | $144.7M | $17.88M | $294.7M | $215.2M | $284.2M | $32.18M | $239.3M | $208.2M |
| Basic EPS | $0.32 | $0.04 | $0.67 | -- | $0.66 | $0.08 | $0.55 | -- |
| **Diluted EPS** | $0.32 | $0.04 | $0.67 | -- | $0.66 | $0.07 | $0.55 | -- |
| Basic Shares Outstanding | 446.0M | 445.1M | 436.8M | -- | 431.9M | 423.5M | 435.5M | -- |
| Diluted Shares Outstanding | 557.0M | 556.9M | 556.8M | -- | 559.6M | 562.3M | 578.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $618.7M | $929.0M | $477.0M | $1.71B | $1.54B | $1.01B | $246.2M |
| Short-Term Investments | $18.80M | $58.20M | $18.30M | $1.30M | $66.00M | $69.98M | $0 |
| **Cash & Short-Term Investments** | $637.5M | $987.2M | $495.3M | $1.71B | $1.61B | $1.08B | $246.2M |
| Other Current Assets | $6.89M | $4.19M | $18.04M | $90.52M | $6.63M | $8.60M | $92K |
| **Total Current Assets** | $1.53B | $1.80B | $1.27B | $2.55B | $2.88B | $2.70B | $832.1M |
| Goodwill | $924.6M | $0 | -- | -- | -- | -- | -- |
| Intangible Assets | -- | -- | -- | $0 | $5.67M | $28.67M | $51.72M |
| Long-Term Investments | $419.0M | $693.5M | $437.1M | $226.3M | $204.4M | $163.0M | $131.3M |
| Other Non-Current Assets | $79.29M | $33.53M | $6.52M | $29.63M | $4.14M | $10.00M | $45.63M |
| **Total Non-Current Assets** | $18.09B | $16.42B | $15.11B | $14.26B | $14.64B | $13.32B | $11.62B |
| **Total Assets** | $19.62B | $18.22B | $16.38B | $16.81B | $17.52B | $16.02B | $12.45B |
| Short-Term Debt | $380.0M | $997.8M | $0 | $997.5M | $0 | $0 | $282.0M |
| Other Current Liabilities | $53.16M | $68.60M | $11.38M | $12.40M | $0 | $18.60M | -- |
| **Total Current Liabilities** | $636.2M | $1.25B | $161.4M | $1.17B | $171.2M | $307.9M | $333.4M |
| Long-Term Debt | $8.57B | $6.61B | $6.14B | $6.12B | $7.10B | $5.82B | $5.96B |
| Other Non-Current Liabilities | $120.8M | $12.08M | $900K | $2.50M | $0 | -- | $0 |
| **Total Non-Current Liabilities** | $9.27B | $6.63B | $6.14B | $6.12B | $7.10B | $5.82B | $5.98B |
| **Total Liabilities** | $9.91B | $7.88B | $6.30B | $7.29B | $7.27B | $6.12B | $6.31B |
| **Total Debt (incl. Leases)** | $8.97B | $7.61B | $6.14B | $7.12B | $7.10B | $5.82B | $6.24B |
| Retained Earnings | $2.36B | $2.85B | $2.52B | $1.96B | $2.26B | $1.92B | $2.83B |
| Accumulated Other Comp. Income | -- | -- | -- | $0 | $16.49M | $34.40M | $2.09M |
| Total Equity | $9.71B | $10.34B | $10.08B | $9.53B | $10.25B | $9.90B | $6.14B |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $513.7M | $812.0M | $586.4M | $618.7M | $938.9M | $631.9M | $1.09B | $929.0M |
| Short-Term Investments | $31.20M | $25.00M | $21.90M | $18.80M | $16.10M | $13.20M | $12.10M | $58.20M |
| **Cash & Short-Term Investments** | $544.9M | $837.0M | $608.3M | $637.5M | $955.0M | $645.1M | $1.10B | $987.2M |
| Other Current Assets | $7.90M | $6.66M | $10.16M | $6.89M | $5.52M | $4.45M | $3.08M | $4.19M |
| **Total Current Assets** | $1.53B | $1.76B | $1.43B | $1.53B | $1.85B | $1.52B | $1.84B | $1.80B |
| Goodwill | $923.5M | $923.5M | $924.6M | $924.6M | $924.6M | $924.6M | -- | $0 |
| Long-Term Investments | $350.0M | $372.1M | $406.8M | $419.0M | $302.5M | $271.9M | $219.0M | $693.5M |
| Other Non-Current Assets | $61.57M | $62.96M | $76.85M | $79.29M | $86.58M | $85.49M | $36.71M | $33.53M |
| **Total Non-Current Assets** | $17.94B | $18.06B | $18.39B | $18.09B | $17.50B | $16.80B | $15.77B | $16.42B |
| **Total Assets** | $19.46B | $19.82B | $19.82B | $19.62B | $19.35B | $18.32B | $17.61B | $18.22B |
| Short-Term Debt | $997.0M | $380.0M | $380.0M | $380.0M | $380.0M | $999.4M | $998.6M | $997.8M |
| Other Current Liabilities | $59.86M | $16.32M | $17.48M | $53.16M | $3.12M | $3.08M | $18.60M | $68.60M |
| **Total Current Liabilities** | $1.18B | $630.9M | $535.7M | $636.2M | $530.8M | $1.21B | $1.18B | $1.25B |
| Long-Term Debt | $7.59B | $8.58B | $8.58B | $8.57B | $8.57B | $7.00B | $6.62B | $6.61B |
| Other Non-Current Liabilities | $122.0M | $108.0M | $117.8M | $120.8M | $126.9M | $143.3M | $17.90M | $12.08M |
| **Total Non-Current Liabilities** | $8.49B | $9.40B | $9.34B | $9.27B | $9.20B | $7.61B | $6.64B | $6.63B |
| **Total Liabilities** | $9.67B | $10.03B | $9.88B | $9.91B | $9.73B | $8.82B | $7.82B | $7.88B |
| **Total Debt (incl. Leases)** | $8.59B | $8.96B | $8.97B | $8.97B | $8.97B | $8.02B | $7.62B | $7.61B |
| Retained Earnings | $2.50B | $2.46B | $2.51B | $2.36B | $2.30B | $2.22B | $2.48B | $2.85B |
| Total Equity | $9.80B | $9.79B | $9.94B | $9.71B | $9.61B | $9.49B | $9.78B | $10.34B |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $1.32B | $1.33B | $1.70B | $230.1M | $1.24B | $1.70B | $2.46B | $1.52B |
| Depreciation & Amortization | $3.85M | $0 | $0 | -- | -- | -- | -- | -- |
| Stock-Based Compensation | $289.9M | $2.34M | $2.36M | $2.17M | $2.44M | $5.43M | $0 | $0 |
| **Operating Cash Flow** | $2.49B | $2.77B | $2.99B | $2.14B | $2.02B | $2.03B | $1.67B | $1.62B |
| Acquisitions, Net | -$74.42M | $0 | $0 | -- | -- | -- | -- | -- |
| Purchases of Investments | -$175.0M | -$150.0M | $0 | -$479.6M | -$70.44M | $0 | -$125.1M | $0 |
| **Investing Cash Flow** | -$1.61B | -$2.68B | -$2.07B | -$1.03B | -$1.87B | -$2.76B | -$2.15B | $303.4M |
| Share Repurchases | -$1.23B | -$229.7M | -$304.8M | $0 | $0 | $0 | -$4.27M | $0 |
| **Financing Cash Flow** | -$1.19B | $361.1M | -$2.15B | -$944.9M | $385.1M | $1.49B | -$1.19B | -$1.38B |
| **Net Change in Cash** | -$310.3M | $452.0M | -$1.23B | $169.7M | $532.4M | $762.5M | -$1.68B | $542.6M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $266.6M | $81.49M | $468.3M | $356.9M | $440.2M | $92.64M | $434.4M | $334.4M |
| Depreciation & Amortization | $1.22M | $1.29M | $1.17M | $1.20M | $1.28M | $1.38M | $0 | -- |
| Stock-Based Compensation | $104.9M | $107.1M | $122.0M | $125.8M | $72.84M | $90.77M | $515K | $525K |
| **Operating Cash Flow** | $686.1M | $728.5M | $718.2M | $827.1M | $702.6M | $364.0M | $596.1M | $742.5M |
| **Investing Cash Flow** | -$285.7M | -$229.7M | -$477.9M | -$847.8M | -$958.3M | -$312.0M | $503.9M | -$505.6M |
| Share Repurchases | -$86.34M | -$44.64M | -$50.10M | -$80.54M | -$146.5M | -$291.6M | -$708.8M | -$52.61M |
| **Financing Cash Flow** | -$698.7M | -$273.1M | -$272.7M | -$299.6M | $562.7M | -$507.8M | -$941.3M | -$258.0M |
| **Net Change in Cash** | -$298.3M | $225.6M | -$32.30M | -$320.2M | $307.0M | -$455.8M | $158.7M | -$21.03M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | 65.6% | 57.1% | 63.4% | 13.7% | 62.5% | 75.2% | 144.6% | 76.0% |
| **Net Profit Margin** | 32.4% | 37.9% | 48.2% | 1.9% | 27.1% | 45.9% | 129.4% | 76.8% |
| Return on Assets (ROA) | 3.9% | 4.7% | 6.9% | 0.3% | 3.5% | 6.1% | 18.9% | -- |
| Current Ratio | 2.40x | 1.44x | 7.90x | 2.19x | 16.81x | 8.76x | 2.50x | -- |
| Quick Ratio | 1.00x | 0.79x | 3.07x | 1.47x | 9.38x | 3.50x | 0.74x | -- |
| **Revenue Growth (YoY)** | +5.1% | -3.9% | +5.2% | -2.3% | +7.9% | +17.0% | +1.1% | -- |
| Operating Income Growth (YoY) | +20.7% | -13.4% | +385.9% | -78.5% | -10.3% | -39.2% | +92.3% | -- |
| **Net Income Growth (YoY)** | -10.2% | -24.3% | +2549.5% | -93.1% | -36.4% | -58.5% | +70.5% | -- |
| EPS Growth (YoY) | -6.8% | -24.4% | +2440.0% | -93.3% | +12.9% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -10.1% | -7.3% | +39.4% | +6.3% | -0.8% | +22.0% | +3.0% | -- |
| 5Y Revenue / Share Growth | -2.1% | -- | -- | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -30.9% | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | 57.1% | 59.6% | 65.1% | 65.6% | 65.2% | 79.8% | 83.9% | 57.1% |
| **Net Profit Margin** | 25.7% | 32.0% | 33.9% | 32.4% | 32.5% | 44.4% | 48.3% | 37.9% |
| Return on Assets (ROA) | 3.5% | 4.1% | 4.2% | 3.9% | 3.9% | 5.6% | 6.2% | 4.7% |
| Current Ratio | 1.29x | 2.80x | 2.66x | 2.40x | 3.48x | 1.26x | 1.56x | 1.44x |
| Quick Ratio | 0.46x | 1.33x | 1.14x | 1.00x | 1.80x | 0.53x | 0.93x | 0.79x |
| **Revenue Growth (YoY)** | +13.3% | +16.5% | +11.0% | +4.8% | +7.9% | +7.7% | 0.0% | -0.4% |
| Operating Income Growth (YoY) | -3.8% | -36.5% | +5.4% | +7.4% | -41.9% | -22.2% | -- | -41.0% |
| **Net Income Growth (YoY)** | -49.1% | -44.4% | +23.1% | +3.4% | -47.8% | -68.5% | +4909.4% | -57.9% |
| EPS Growth (YoY) | -51.5% | -50.0% | +21.8% | -- | -45.9% | -65.2% | +5400.0% | -- |
| Operating Cash Flow Growth (YoY) | -2.4% | +100.1% | +20.5% | +11.4% | -0.1% | -44.7% | -10.3% | -3.9% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
